Melanoma & Skin Cancer | Specialty

Updates and Advances in Basal Cell Carcinoma

December 18th 2020

Although basal cell carcinoma generally has a good prognosis, improving tolerance to targeted Hedgehog inhibitors and optimizing second-line treatment with immune checkpoint inhibitors are important for the small subset of patients who develop locally advanced or metastatic disease.

Dr. Sznol on the Challenges of Managing Immune-Related Toxicities in Melanoma

December 16th 2020

Mario Sznol, MD, discusses the challenges of managing immune-related toxicities in melanoma.

Nivolumab/Ipilimumab Combo Shows Antitumor Activity in Metastatic Uveal Melanoma

December 16th 2020

December 16, 2020 — The combination of nivolumab with ipilimumab demonstrated activity in patients with metastatic uveal melanoma with encouraging responses.

Dr. Atkins on the Benefits of Neoadjuvant Therapy in Melanoma

December 15th 2020

Michael B. Atkins, MD, discusses the benefits of neoadjuvant therapy in melanoma.

Dr. Sullivan on Treatment Options in BRAF-Mutant Melanoma

December 15th 2020

Ryan Sullivan, MD, discusses treatment options in BRAF-mutant melanoma.

Sznol Advocates for More Awareness of Immune-Related Toxicities in Oncology

December 14th 2020

Mario Sznol, MD, discusses the critical importance of being aware of the immune-related toxicities that could arise when treating patients with cancer, along with the best ways to manage them.

Modern Perspectives in Advanced Melanoma

December 14th 2020

Dr. Weber on Unmet Needs in Melanoma

December 9th 2020

Jeffrey S. Weber, MD, PhD, discusses unmet needs in melanoma.

Dr. Tawbi on Future Research Efforts in Melanoma

December 8th 2020

Hussein A. Tawbi, MD, PhD, discusses future research efforts in melanoma.

Robert Recaps a Career of Clinical Research in Melanoma

December 7th 2020

In our exclusive interview, Caroline Robert, MD, PhD, discusses her groundbreaking work on clinical trials evaluating anti–CTLA-4 and anti–PD-1 antibodies in advanced melanoma, her experiences as a researcher in France and the United States, her love of traveling, and next steps for the field.